Innatrix Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2013

Location

Durham NC US

Primary Industry

Biotechnology

About

Based in NC, US, and founded in 2013 by John Salmeron, Innatrix Inc. develops biological and chemical treatments using patented protein evolution technology to control untreatable crop diseases, pests, and weeds. In March 2022, Innatrix raised Seed funding from SOSV. As of 2022, Jiarui Li is the CEO of the company. The company is developing EvoStat™, which is an automated platform for protein engineering via continuous laboratory evolution or other approaches such as phage display or SIP-phage display. The EvoStat™ provides advanced control, reporting, recording, simulation, and remote access and is available for plotting and analysis. The firm's other products in the pipeline include InnaLB™ (potato late blight), InnaNema™ (soybean cyst nematode), and InnaHLB™ (citrus greening). Innatrix's services include specialties, biological products, chemical research, eco-friendly products, and modern technology.

Current Investors

National Science Foundation, One North Carolina Small Business Program, Innova Memphis

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biotechnology

Website

www.innatrix.com

Verticals

Agtech

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.